» Articles » PMID: 39862805

Topologically Constrained DNA-mediated One-pot CRISPR Assay for Rapid Detection of Viral RNA with Single Nucleotide Resolution

Overview
Journal EBioMedicine
Date 2025 Jan 25
PMID 39862805
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The widespread and evolution of RNA viruses, such as the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), highlights the importance of fast identification of virus subtypes, particularly in non-laboratory settings. Rapid and inexpensive at-home testing of viral nucleic acids with single-base resolution remains a challenge.

Methods: Topologically constrained DNA ring is engineered as substrates for the trans-cleavage of Cas13a to yield an accelerated post isothermal amplification. The capacity of CRISPR/Cas13a for discriminating single nucleotide variant (SNV) in viral genome is leveraged by designing synthetic mismatches and hairpin structure in CRISPR RNA (crRNA), enabling robust discrimination of different SARS-CoV-2 variants. Via optimisation of CasTDR to be one-pot assay, CasTDR can detect Omicron and its subvariants, with only a few copies in clinical samples in less than 30 min without pre-amplification.

Findings: The detection system boasts high sensitivity (0.1 aM), single-base specificity, and the advantage of a rapid "sample-to-answer" process, which takes only 30 min. In the detection of SARS-CoV-2 clinical samples and their variant strains, CasTDR has achieved 100% accuracy. Furthermore, the design of a portable signal-reading device facilitates user-friendly result interpretation. For the detection needs of different RNA viruses, the system can be adapted simply by designing the corresponding crRNA.

Interpretation: Our study provides a rapid and accurate molecular diagnostic tool for point-of-care testing, epidemiological screening, and the detection of diseases associated with other RNA biomarkers with excellent single nucleotide differentiation, high sensitivity, and simplicity.

Funding: National Key Research and Development Program of China (No. 2023YFB3208302), National Natural Science Foundation of China (No. 22377110, 22034004, 82402749, 82073787, 22122409), National Key Research and Development Program of China (No. 2021YFA1200104), Henan Province Fund for Cultivating Advantageous Disciplines (No. 222301420019).

Citing Articles

Revolutionizing CRISPR-based RNA diagnostics with single nucleotide resolution.

Liu H, Xiu L, Li Q, Yin K EBioMedicine. 2025; 113:105617.

PMID: 39978268 PMC: 11871498. DOI: 10.1016/j.ebiom.2025.105617.

References
1.
Gao H, Feng M, Li F, Zhang K, Zhang T, Zhang Z . G-Quadruplex DNAzyme-Substrated CRISPR/Cas12 Assay for Label-Free Detection of Single-Celled Parasitic Infection. ACS Sens. 2022; 7(10):2968-2977. DOI: 10.1021/acssensors.2c01104. View

2.
Seok Y, Mauk M, Li R, Qian C . Trends of respiratory virus detection in point-of-care testing: A review. Anal Chim Acta. 2023; 1264:341283. PMC: 10163836. DOI: 10.1016/j.aca.2023.341283. View

3.
Wang Y, Peng Y, Liu S, Li M, Pei X, Tong Y . CRISPR/Cas12a coupled with loop-mediated isothermal amplification and lateral flow assay for SARS-CoV-2 detection. Anal Methods. 2024; 16(35):5971-5981. DOI: 10.1039/d4ay00757c. View

4.
Kaminski M, Abudayyeh O, Gootenberg J, Zhang F, Collins J . CRISPR-based diagnostics. Nat Biomed Eng. 2021; 5(7):643-656. DOI: 10.1038/s41551-021-00760-7. View

5.
Li Y, Wu Y, Xu R, Guo J, Quan F, Zhang Y . In vivo imaging of mitochondrial DNA mutations using an integrated nano Cas12a sensor. Nat Commun. 2023; 14(1):7722. PMC: 10673915. DOI: 10.1038/s41467-023-43552-0. View